BioReliance VP of Sales Salaries in Ithaca, NY | Comparably
BioReliance is a leading CRO providing nonclinical testing and contract manufacturing services. read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
126

BioReliance VP of Sales Salaries in Ithaca, NY

The average BioReliance VP of Sales in Ithaca, NY earns an estimated $302,612 annually, which includes an estimated base salary of $194,216 with a $108,395 bonus. BioReliance's VP of Sales compensation is $2,333,585 less than the US average for a VP of Sales. VP of Sales salaries at BioReliance in Ithaca, NY can range from $125,467 - $700,000.

In Ithaca, NY, The Sales Department at BioReliance earns $1,783 more on average than the IT Department.

Last updated 2 years ago.

$60k
$122k
$212k
$300k
$3.56B
$302,612
Average Compensation
$194,216
avg. base
$108,395
avg. bonus

VP of Sales Salaries at BioReliance

In Ithaca, NY, VPs of Sales earn $75,218 more than Directors of Sales.

Director of Sales
$227k*
Sales Engineer
$150k*
Sales Manager
$149k*
Sales Rep
$130k*
Sales Associate
$64k*
* estimated salary

Compensation at BioReliance by Department

In Ithaca, NY, The Sales Department averages $1,783 more than the IT Department, and $5,418 less than the HR Department

HR
$109,608 Avg. total comp.
+$5k
Sales
$104,190 Avg. total comp.
IT
$102,407 Avg. total comp.
-$2k

VP of Sales Compensation by Gender (All Companies)

The average female VP of Sales at companies similar size to BioReliance reported making $326,625, while the average male VP of Sales at similar sized companies reported making $314,005.

VP of Sales Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Sales at companies similar size to BioReliance reported making $371,333, while the average Asian or Pacific Islander VP of Sales at similar sized companies reported making $260,050.

How VPs of Sales at BioReliance Rate Their Compensation

The majority of VPs of Sales at BioReliance believe they're compensated fairly. 50% of VPs of Sales at BioReliance say they receive annual bonuses, and the vast majority (75%) are satisfied with their benefits. See more compensation ratings at BioReliance

×
Rate your company